| Vol.11, Issue.3.67 | 2017-09-21 | Pages
Pathogenetic substantiation of using selenium-containing drugs for the correct disorders of the blood plasma fibrinolytic system in patients with chronic diffuse liver diseases and euthyroid syndrome pathology
The dynamics of the indices of fibrinolysis and cellular adhesion in patients with chronic diffuse liver diseases and euthyroid syndrome against the ground of administration of selenium-containing drugs, has been studied. The administration of selenium-containing drugs in a comprehensive therapy of patients with chronic diffuse liver diseases with disorders of thyroid homeostasis was found to improve the indices of the blood plasma fibrinolytic system, to reduce adhesive cellular properties and to increase total enzymatic activity of the blood plasma.
Original Text (This is the original text for your reference.)
Pathogenetic substantiation of using selenium-containing drugs for the correct disorders of the blood plasma fibrinolytic system in patients with chronic diffuse liver diseases and euthyroid syndrome pathology
The dynamics of the indices of fibrinolysis and cellular adhesion in patients with chronic diffuse liver diseases and euthyroid syndrome against the ground of administration of selenium-containing drugs, has been studied. The administration of selenium-containing drugs in a comprehensive therapy of patients with chronic diffuse liver diseases with disorders of thyroid homeostasis was found to improve the indices of the blood plasma fibrinolytic system, to reduce adhesive cellular properties and to increase total enzymatic activity of the blood plasma.
+More
indices of fibrinolysis and cellular adhesion thyroid homeostasis adhesive cellular properties enzymatic activity blood plasma fibrinolytic system
APA
MLA
Chicago
K.A. Chympoy,.Pathogenetic substantiation of using selenium-containing drugs for the correct disorders of the blood plasma fibrinolytic system in patients with chronic diffuse liver diseases and euthyroid syndrome pathology. 11 (3.67),.
Select your report category*
Reason*
New sign-in location:
Last sign-in location:
Last sign-in date: